GPT-Rosalind advances life sciences research with enhanced biological reasoning, medicinal chemistry expertise, genomics analysis, and experimental workflow capabilities.
Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at OpenAI Blog.
OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
OpenAI launches Rosalind Biodefense, expanding trusted access to GPT-Rosalind for vetted developers and U. S.
OpenAI and Molecule. one show how a near-autonomous AI chemist using GPT-5.
arXiv:2608. 02642v1 Announce Type: cross Abstract: Accelerating scientific discovery is among the most consequential applications of AI, and computational biomolecular simulation stands out as a particularly promising target within this broader effort.
Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.
César de la Fuente’s laboratory employs Codex and ChatGPT to explore both living and extinct genomes in search of novel antimicrobial molecules. By leveraging these AI tools, the team aims to identify candidates that could help combat drug‑resistant infections.